MRK vs GEHC
By Alex · Tickerpine
Merck & Company, Inc. vs GE HealthCare Technologies Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | GEHC |
|---|---|---|
| Price | $132.92 | $72.28 |
| Market cap | $327.94B | $32.65B |
| P/E ratio | 106.3 | 16.7 |
| ROE | 6.96% | 19.38% |
| Profit margin | 4.77% | 9.33% |
| Revenue growth | 5.10% | 5.80% |
| Dividend yield | 2.56% | 0.19% |
| Beta | 0.21 | 0.82 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs GEHC in plain English
- MRK is the bigger company — about 10.0× the market cap of GEHC.
- GEHC is cheaper on earnings (P/E 16.7 vs 106.3).
- GEHC earns a higher return on equity (19% vs 7%).
- GEHC is growing revenue faster (6% vs 5%).
- MRK has the higher dividend yield (2.56% vs 0.19%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Company, Inc. would be worth today.
GEHC return calculator
See what $1,000 in GE HealthCare Technologies Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.